Related Experiment Video
Updated: Oct 26, 2025
05:57
Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
Published on: May 17, 2024
899
Is resistance training alone an antihypertensive therapy? A meta-analysis
Odilon Abrahin1, Renilson Moraes-Ferreira2, Erik Artur Cortinhas-Alves3
1Universidade Federal do Pará-UFPA, Pós-Graduação em Genética e Biologia Molecular, Belém, PA, Brazil. odilonsalim@hotmail.com.
Journal of Human Hypertension
|July 29, 2021
Summary
Isolated resistance training (RT) significantly lowers systolic and diastolic blood pressure in individuals with hypertension. This meta-analysis confirms RT
Area of Science:
- Exercise Physiology
- Cardiovascular Health
- Clinical Nutrition
Background:
- Limited evidence exists on isolated resistance training (RT) for hypertensive individuals.
- Current guidelines offer divergent recommendations regarding RT for prehypertensive and hypertensive populations.
- Meta-analyses with larger sample sizes are needed for robust effect size estimation and clinical decision-making.
Purpose of the Study:
- To evaluate the impact of isolated resistance training (RT) on systolic blood pressure (SBP) and diastolic blood pressure (DBP).
- To assess the effectiveness of RT alone in prehypertensive and hypertensive individuals.
Main Methods:
- A meta-analysis was conducted using data from 13 studies.
- A total of 417 participants were included (207 in RT groups, 210 in control groups).
Main Results:
- Significant reductions in SBP were observed (-6.16 mmHg).
- Significant reductions in DBP were observed (-3.70 mmHg).
- These reductions were compared to control groups, with low heterogeneity noted.
Conclusions:
- Isolated resistance training (RT) effectively reduces both SBP and DBP in prehypertensive and hypertensive individuals.
- The benefits of RT are particularly notable in elderly individuals.
- RT can be considered a viable intervention for blood pressure management.
Related Concept Videos
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
603
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
603
01:28Hypertension IV: Drug Therapy and Lifestyle Modifications
154
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
154
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
1.9K
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
1.9K
01:17Antihypertensive Drugs: Action of β1 Blockers
1.5K
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
1.5K
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
1.8K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
1.8K
01:25Antihypertensive Drugs: Direct Renin Inhibitors
943
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
943